Parasite vs. Avengers: Endgame: Box Office & Theatrical Economics Faceoff

Parasite vs. Avengers: Endgame: Theatrical Economics, P&A Recoupment & Studio Return

In evaluating the commercial faceoff between Parasite and Avengers: Endgame, worldwide ticket receipts provide only the top-line baseline of cinematic profitability. Avengers: Endgame captured higher aggregate worldwide box office gross of $2.80 Billion, establishing a $2536 million gross advantage over Parasite's $263 Million.

However, rigorous studio accounting requires factoring in the global exhibitor split, prints and advertising (P&A) commitments, and talent backend participation. Applying the standard Hollywood blended 50% distributor rental take, Avengers: Endgame converted its theatrical receipts into approximately $1399.5 million in studio rentals, providing the vital cash flow necessary to offset its $356M production budget and global marketing campaign.

From a pure capital efficiency standpoint, Parasite achieved superior return on invested capital, delivering an impressive 16.95x recoupment multiple against its initial production budget, compared to 7.86x for Avengers: Endgame. In critical evaluation, Parasite leads the artistic consensus with a Certified Fresh score of 99%, demonstrating that commercial velocity and critical standing can align effectively in modern franchise distribution.

Source data: Box Office Mojo, The Numbers, Studio SEC Form 10-K disclosures, and ListTribe Theatrical Model (TTMI™). Verified September 2026.